INMB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

INmune Bio (INMB) Earnings Date & Reports

INmune Bio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

INMB is expected to report earnings to rise 6.44% to -45 cents per share on July 30

Q2'25

Est.

$-0.46

Q1'25

Beat

by $0.06

Q4'24

Beat

by $0.15

Q3'24

Missed

by $0.08

Q2'24

Beat

by $0.13

The last earnings report on May 08 showed earnings per share of -43 cents, beating the estimate of -49 cents. With 72.03K shares outstanding, the current market capitalization sits at 164.11M.

View a ticker or compare two or three

Compare

INMB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For INMB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for INMB (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 NE Mizner Boulevard

Phone

+1 858 964-3720

Employees

Web

https://www.inmunebio.com